Floatz logo

Cart-19 Cells

Burkitt Lymphoma

Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyCell therapyPhase 3Active
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
81/ 100

Competitive context

73 Active assets in the Burkitt Lymphoma cohort.

Asset / SponsorPhaseRating
FILGRASTIM
Fred Hutchinson Cancer Center
Phase 4BBB
VINCRISTINE SULFATE
AIDS Malignancy Consortium
Phase 2BBB
VINDESINE
PETHEMA Foundation
Phase 4BBB
CYCLOSPORIN A
Fred Hutchinson Cancer Center
Phase 2BBB
Cyclophosphamide
AIDS Malignancy Consortium
Phase 4BBB

View all 50 →

Same molecule, other indications

Cart-19 Cells is also rated in:

B-cell non-Hodgkin lymphomaDormant
BB
Indicative ·
64 / 100
View asset →
B-cell acute lymphoblastic leukemiaDormant
B
Indicative ·
61 / 100
View asset →
acute lymphoblastic leukemiaDormant
CCC
Indicative ·
54 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →